With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.33454-82-9,Lithium trifluoromethanesulfonate,as a common compound, the synthetic route is as follows.
In an Ar filled flask, 0.150 g (0.24 mmol) of [RuCI(p- cymene)(R,R-TsDPEN)] and 0.037 g (0.24 mmol) of LiOTf were combined.
33454-82-9, As the paragraph descriping shows that 33454-82-9 is playing an increasingly important role.
Reference£º
Patent; KANATA CHEMICAL TECHNOLOGIES INC.; WO2009/132443; (2009); A1;,
Metal catalyst and ligand design
Ligand Template Strategies for Catalyst Encapsulation – NCBI